Skip to main content
Journal cover image

Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE.

Publication ,  Journal Article
Zeitler, EP; Friedman, DJ; Loring, Z; Campbell, KB; Goldstein, SA; Wegermann, ZK; Schutz, J; Smith, N; Black-Maier, E; Al-Khatib, SM; Piccini, JP
Published in: Heart Rhythm
March 2020

BACKGROUND: Reports on the subcutaneous implantable cardioverter-defibrillator (S-ICD) cumulatively demonstrate a low rate of complications, but clinical experience with this technology is limited compared with transvenous devices. OBJECTIVE: The purpose of this study was to describe and analyze S-ICD complications reported to the Food and Drug Administration's Manufacturer and User Facility Device Experience database. METHODS: We reviewed all S-ICD events reported to the Manufacturer and User Facility Device Experience submitted over 24 months (from February 2016 through February 2018) through a prospective and standardized approach at a time when an estimated 15,000 S-ICDs were in service. RESULTS: After removing duplicate entries and nonclinical events (n = 493), 1604 events remained. A total of 542 instances of infection were reported with system removal in 414/542 (77.5%). Inappropriate shocks occurred in 550 patients, and 382 (69%) were attributed to oversensing; in response, 254 (56%), 147 (33%), and 80 (18%) patients underwent system reprogramming, removal, or revision, respectively. There were 15 deaths, and causes included defibrillation failure during follow-up (n = 2), ventricular fibrillation induced by the device (n = 4), device-device interaction resulting in undersensing (n = 1), procedure-related complications (n = 4), and uncertain etiology (n = 4). There were 137 reports of system migration, and in 57 (42%) of these, there were associated inappropriate shocks. System migration events were managed with a combination of system revision (69 [51%]), reprogramming (25 [18%]), and system removal (44 [32%]). CONCLUSION: Several S-ICD complications have been reported that appear to be related to the ICD's design and function over time. A better understanding of these complications may help inform patient selection, implant technique, and postimplantation management.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Heart Rhythm

DOI

EISSN

1556-3871

Publication Date

March 2020

Volume

17

Issue

3

Start / End Page

447 / 454

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Survival Rate
  • Retrospective Studies
  • Male
  • Humans
  • Female
  • Equipment Failure
  • Defibrillators, Implantable
  • Death, Sudden, Cardiac
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zeitler, E. P., Friedman, D. J., Loring, Z., Campbell, K. B., Goldstein, S. A., Wegermann, Z. K., … Piccini, J. P. (2020). Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE. Heart Rhythm, 17(3), 447–454. https://doi.org/10.1016/j.hrthm.2019.09.024
Zeitler, Emily P., Daniel J. Friedman, Zak Loring, Kristen B. Campbell, Sarah A. Goldstein, Zachary K. Wegermann, Jane Schutz, et al. “Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE.Heart Rhythm 17, no. 3 (March 2020): 447–54. https://doi.org/10.1016/j.hrthm.2019.09.024.
Zeitler EP, Friedman DJ, Loring Z, Campbell KB, Goldstein SA, Wegermann ZK, et al. Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE. Heart Rhythm. 2020 Mar;17(3):447–54.
Zeitler, Emily P., et al. “Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE.Heart Rhythm, vol. 17, no. 3, Mar. 2020, pp. 447–54. Pubmed, doi:10.1016/j.hrthm.2019.09.024.
Zeitler EP, Friedman DJ, Loring Z, Campbell KB, Goldstein SA, Wegermann ZK, Schutz J, Smith N, Black-Maier E, Al-Khatib SM, Piccini JP. Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE. Heart Rhythm. 2020 Mar;17(3):447–454.
Journal cover image

Published In

Heart Rhythm

DOI

EISSN

1556-3871

Publication Date

March 2020

Volume

17

Issue

3

Start / End Page

447 / 454

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Survival Rate
  • Retrospective Studies
  • Male
  • Humans
  • Female
  • Equipment Failure
  • Defibrillators, Implantable
  • Death, Sudden, Cardiac